How Much Does Insulin Cost in the US?

For the estimated 8.4 million Americans who depend on insulin to manage their diabetes, the cost of this life-sustaining medication is one of the most pressing healthcare concerns in the country. Insulin pricing in the United States has historically been among the highest in the world — but recent policy changes, the rise of biosimilar insulins, and expanded patient assistance programs are beginning to shift the landscape.
This comprehensive guide breaks down insulin costs in the US, explains the factors that influence pricing, and outlines options for reducing out-of-pocket expenses.

A Brief Overview of Insulin Types and Their Uses

Before examining costs, it helps to understand the different types of insulin available in the US and what each is used for.
Insulin Type
Examples
Action
Typical Use
Rapid-acting
Humalog, NovoLog, Admelog
Starts in 15 min; peaks 1 hr
Before meals
Short-acting
Regular insulin (Humulin R)
Starts in 30 min; peaks 2–3 hr
Before meals
Intermediate-acting
NPH (Humulin N)
Starts in 2–4 hr; peaks 4–12 hr
Background coverage
Long-acting
Lantus, Basaglar, Toujeo
Lasts 20–24 hr; no peak
Once-daily background
Ultra-long-acting
Tresiba
Lasts 42+ hr
Once-daily background
Premixed
70/30 mixes
Combination
Simplified regimens
People with Type 1 diabetes typically require multiple types of insulin daily. Many people with Type 2 diabetes may use one or two types.

How Much Does Insulin Cost in the US?

Insulin prices vary significantly depending on the brand, type, pharmacy, insurance status, and state of purchase.

Brand-Name Insulin Without Insurance

Brand-name insulin from the three major US manufacturers — Eli Lilly, Novo Nordisk, and Sanofi — has historically been extremely expensive at list price.
Insulin
Manufacturer
List Price Per Vial (10mL)
Humalog (lispro)
Eli Lilly
~$274
NovoLog (aspart)
Novo Nordisk
~$289
Lantus (glargine)
Sanofi
~$292
Toujeo (glargine U-300)
Sanofi
~$340
Tresiba (degludec)
Novo Nordisk
~$316
Most patients use approximately 2–4 vials per month, putting the uninsured list-price cost at $$500$$1,100+ per month for brand-name insulin.

The Insulin Price Cap: A Major Change

In 2023, all three major insulin manufacturers announced significant price reductions under a combination of public pressure and federal policy:
  • Eli Lilly capped out-of-pocket insulin costs at $35/month for most insulins
  • Novo Nordisk capped patient cost at $35/month for its insulins
  • Sanofi introduced similar $35/month caps
Additionally, the Inflation Reduction Act of 2022 capped out-of-pocket insulin costs at $35 per month for Medicare Part D enrollees — a landmark policy change that took effect in 2023.

Biosimilar and Generic Insulin Options

The growing availability of biosimilar insulins has dramatically expanded affordable options in the US market.

What Is a Biosimilar Insulin?

A biosimilar is a highly similar (but not identical) version of a biologic drug — in this case, insulin — approved by the FDA as having no clinically meaningful differences from the reference product.

Key Biosimilar Insulins Available in the US

Biosimilar
Reference Product
Manufacturer
Retail Price (Per Vial)
Semglee (glargine)
Lantus
Viatris/Biocon
~$$98 (list) / $$30 (authorized generic)
Rezvoglar (lispro)
Humalog
Eli Lilly
~$92 (list)
Insulin lispro (generic)
Humalog
Various
~$$35$$50
Admelog (lispro)
Humalog
Sanofi
~$120

Over-the-Counter Insulin

Walmart and some other US retailers sell ReliOn brand insulin over the counter without a prescription for approximately $25 per vial. This includes NPH and Regular (R) insulin. These are older formulations and may not be appropriate for all patients, but they represent an accessible option in emergencies.

Cost With Insurance

For most insured Americans, actual out-of-pocket insulin costs are far lower than list prices.
Insurance Type
Typical Monthly Out-of-Pocket
Private insurance (with coverage)
$$25$$100+ (varies by plan tier)
Medicare Part D (2023+)
Capped at $35/month
Medicaid
Very low to $0 (state-dependent)
High-deductible plans (before deductible)
Can reach list price
Employer plans with insulin cap
$35/month (varies by plan)
Insurance coverage for insulin depends on the specific plan’s formulary — the list of covered drugs. Not all insulin brands are covered by all plans, and tier placement affects copay amounts. Switching to a formulary-preferred biosimilar or generic can significantly reduce costs.

Ways to Reduce Insulin Costs in the US

If you are struggling with insulin costs, there are several practical options to explore.

1. Manufacturer Savings Programs

All three major insulin manufacturers offer patient savings programs:
  • Lilly Insulin Value Program: $35/month cap at participating pharmacies
  • Novo Nordisk Patient Assistance: Free insulin for uninsured or underinsured patients who qualify
  • Sanofi Insulins VALYou Savings Program: Savings for qualifying patients

2. GoodRx and Discount Cards

GoodRx and similar discount programs can reduce insulin prices at participating pharmacies by 20–80%. Prices vary by ZIP code, pharmacy, and insulin type. GoodRx is free to use.

3. Biosimilar Substitution

Ask your doctor or pharmacist whether a biosimilar or authorized generic version of your insulin is available. Semglee, for example, is interchangeable with Lantus and available at a fraction of the price.

4. Community Health Centers

Federally Qualified Health Centers (FQHCs) across the US operate on sliding-scale fees and often provide discounted or free medications through the 340B Drug Pricing Program. Find a center near you at findahealthcenter.hrsa.gov.

5. State Prescription Assistance Programs

Many US states have implemented their own insulin affordability programs. California, Colorado, Maine, and several other states have laws capping out-of-pocket insulin costs at $35 or less per month regardless of insurance status.

6. Insulin Manufacturers’ Free Programs

Patients who are uninsured and meet income criteria may qualify for free insulin directly from manufacturers. Novo Nordisk’s “Changing the Present” program and Lilly’s Insulin Value Program are starting points.

The Bigger Picture: Why Is Insulin So Expensive in the US?

The US insulin market has been shaped by several structural factors:
  • No single-payer pricing negotiation: Unlike most developed countries, the US historically lacked federal authority to negotiate drug prices at scale (though the IRA changed this for Medicare)
  • Patent layering and product hopping: Manufacturers extend market exclusivity by making minor product modifications
  • Pharmacy benefit manager (PBM) influence: PBMs negotiate rebates that don’t always flow to patients
  • Lack of generic competition until recently: Insulin is a biologic, not a small molecule, making generic development more complex
The arrival of biosimilars and federal policy caps is beginning to change the landscape, but the system remains complex.

Monthly Insulin Cost Summary

Scenario
Estimated Monthly Cost
Insured (good coverage, formulary drug)
$$25$$100
Medicare Part D (2023+)
Up to $35
Uninsured, brand-name (no assistance)
$$500$$1,100+
Biosimilar or authorized generic
$$30$$150
OTC insulin (Walmart ReliOn)
~$25/vial
With manufacturer savings program
$35
With GoodRx discount
$$30$$200 (varies)

Frequently Asked Questions (FAQ)

How much does insulin cost per month in the US without insurance?

Without insurance and without a savings program, brand-name insulin can cost $$500$$1,100 or more per month depending on the type and quantity needed. However, manufacturer price caps, biosimilar alternatives, and GoodRx can dramatically reduce this cost to as low as $$35$$150 per month.

Is insulin covered by Medicare?

Yes. As of January 2023, Medicare Part D caps out-of-pocket insulin costs at $35 per month for covered insulins. Medicare Part B may also cover insulin used with an insulin pump.

What is the cheapest insulin available in the US?

The cheapest over-the-counter option is Walmart’s ReliOn NPH or Regular insulin at approximately $25 per vial without a prescription. Among modern insulins, authorized generics of glargine and lispro are available for $$30$$50 per vial through discount programs.

Can I get insulin for free in the US?

Yes, in certain circumstances. Patients who are uninsured or underinsured and meet income guidelines may qualify for free insulin through manufacturer patient assistance programs. Community health centers and nonprofit organizations such as the Patient Advocate Foundation also provide assistance.

Why does insulin cost so much more in the US than in other countries?

The US historically lacked the price negotiation mechanisms used in other countries. List prices set by manufacturers are negotiated between PBMs, insurers, and pharmacies — but the savings don’t always reach patients. Policy changes under the Inflation Reduction Act and manufacturer price caps are beginning to address this disparity.

This article is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider or pharmacist regarding insulin options, dosing, and cost-saving strategies appropriate for your situation.

Advertisement

Advertisement
Back to top button